CAS Medical Systems, Inc. (Nasdaq:CASM) announced that it has closed a private placement with Thomas, McNerney & Partners for the issuance of a combination of a Convertible Preferred Stock and non-voting Exchangeable Preferred Stock for gross proceeds of $15,000,000. The Company intends to use the proceeds to fund its ongoing operating and growth initiatives related to its FORE-SIGHT(R) Absolute Tissue Oximeter business and its Traditional Monitoring Products segment.

CAS Medical Systems, Inc. develops and manufactures medical devices